TCR2 THERAPEUTICS INC. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q1 2023

Taxonomy & unit: us-gaap: USD/shares
Description: The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary: Tcr2 Therapeutics Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q1 2023.
Tcr2 Therapeutics Inc. Earnings Per Share, Basic for the quarter ending March 31, 2023 was -1.03 USD/shares, a 35.5% decline year-over-year.
Tcr2 Therapeutics Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2023 was -4.2 USD/shares.
Tcr2 Therapeutics Inc. annual Earnings Per Share, Basic for 2022 was -3.93 USD/shares, a 49.4% decline from 2021.

Earnings Per Share, Basic, Trailing 12 Months (USD/shares)

Earnings Per Share, Basic, Quarterly (USD/shares)

Earnings Per Share, Basic, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q1 2023	-$4	-$1	$0	-35.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	-$4	-$2			Oct 1, 2022	Dec 31, 2022	10-K	2023-03-23
Q3 2022		-$1	$0	-14.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2022-11-08
Q2 2022		-$1	$0	-28.1%	Apr 1, 2022	Jun 30, 2022	10-Q	2022-08-08
Q1 2022		-$1			Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-11
Q3 2021		-$1			Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-08
Q2 2021		-$1			Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.